Gene Editing of Human Embryos with CRISPR/Cas9: Great Promise Coupled with Important
      Caveats

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Contributors

Seppo Ylä-Herttuala

Journal

Journal ID (nlm-ta): Mol Ther

Journal ID (iso-abbrev): Mol. Ther

Title: Molecular Therapy

Publisher: American Society of Gene & Cell Therapy

ISSN (Print): 1525-0016

ISSN (Electronic): 1525-0024

Publication date (Print): 07 March 2018

Publication date (Electronic): 22 February 2018

Volume: 26

Issue: 3

Pages: 659-660

Affiliations

[1 ]A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland

[2 ]Heart Center and Gene Therapy Unit, Kuopio University Hospital, 70211 Kuopio, Finland

Author notes

[∗ ]Corresponding author: Seppo Ylä-Herttuala, MD, PhD, FESC, Editor-in-Chief, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, Kuopio 70211, Finland. seppo.ylaherttuala@ 123456uef.fi

Article

Accession ID: PMC5911640 Pmcid ID: PMC5911640 Pmc-uid ID: 5911640 Publisher ID: S1525-0016(18)30060-1

DOI: 10.1016/j.ymthe.2018.02.007

PMC ID: 5911640

PubMed ID: 29477495

SO-VID: f1064951-65aa-4071-be73-d2520208e9d8

History

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Gene Editing of Human Embryos with CRISPR/Cas9: Great Promise Coupled with Important Caveats

Read this article at